Filter
510
Filtered Results: 510
Text search:
methyl
Featured
Recommendations
78
New Publications
129
Language
Document type
No document type
299
Guidelines
109
Studies & Reports
51
Manuals
27
Training Material
8
Strategic & Response Plan
7
Fact sheets
6
Resource Platforms
2
Infographics
1
Countries / Regions
India
41
Ethiopia
18
Global
13
Kenya
12
Western and Central Europe
12
Nigeria
10
South Africa
9
Indonesia
8
Latin America and the Carribbean
8
Uganda
7
Philippines
6
Nepal
6
Germany
6
Sierra Leone
5
Russia
5
USA
4
Syria
4
Tanzania
4
Malawi
4
Mozambique
4
Brazil
4
Myanmar / Burma
4
Africa
4
Liberia
3
Senegal
3
Ghana
3
Zimbabwe
3
Zambia
3
Eswatini/ Swaziland
3
Eastern Europe
3
Burkina Faso
2
Cameroon
2
Rwanda
2
Bangladesh
2
Namibia
2
Botswana
2
Bosnia and Herzegovina
2
Guinea-Bissau
1
Saudi Arabia
1
Haiti
1
Iraq
1
Afghanistan
1
Lebanon
1
Chad
1
China
1
Malaysia
1
Papua New Guinea
1
Central African Republic
1
Serbia
1
Ukraine
1
Libya
1
Angola
1
Madagascar
1
Lesotho
1
Chile
1
Yemen
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Asia
1
Solomon Islands
1
Bhutan
1
Albania
1
Mongolia
1
Tajikistan
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
Turkmenistan
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
189
Clinical Guidelines
72
Public Health
27
Women & Child Health
20
Pharmacy & Technologies
20
Key Resources
13
Capacity Building
6
Toolboxes
Mental Health
100
Pharmacy
37
COVID-19
35
Rapid Response
18
TB
15
AMR
15
NTDs
15
Specific Hazards
13
NCDs
13
Caregiver
10
Planetary Health
9
Zika
8
Conflict
6
Ebola
5
Natural Hazards
5
Refugee
5
HIV
5
Disability
4
Cholera
1
Global Health Education
1
WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
recommended
2nd edition, July 2021. This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. It includes some important shifts in WHO’s recommended approaches to cervical screening, and includes a total of 23 recommendati...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
The standards for the care of small and sick newborns in health facilities define, standardize and mainstream inpatient care of small and sick newborns, building on essential newborn care and ensuring consistency with the WHO quality of care framework. The standards will guide countries in caring fo...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
16.7.2021
J Pharm Pharm Sci (www.cspsCanada.org) 16(3) 441 - 455, 2013
24 Nov. 2021; This guidance provides considerations and a series of options that can be used to inform country strategies to minimise risk associated with shortages of personal protective equipment (PPE).
Re-use and reprocessing of single use PPE must be a last-resort temporary measure that is impl...
WHO/UNICEF/UNFPA joint statement
Glaucoma, a disease that gradually affects the optic nerve, is the second leading cause of vision loss globally, and it continues to pose a challenge to the eye health professionals.
Ongoing Living Update of COVID-19 Therapeutic Options: Summary of Evidence, Rapid Review 22 February 2022
recommended
This document includes the results of a rapid systematic review of current available literature. The information included in this review reflects the evidence as of the date posted in the document. In recognition of the fact that there are numerous ongoing clinical studies, PAHO will periodically up...
The strategic framework gives guidance to public and private health facilities and health workers on compliance with standards relating to IPC practices. To further assist health facilities to implement the IPC strategic framework, this practical implementation manual has been developed in parallel ...
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau...
En 2015, murieron 5,9 millones de niños menores de cinco años (1). Las principales causas de muerte en los niños a nivel mundial son la neumonía, la prematuridad, las complicaciones durante el parto, la sepsis neonatal, las anomalías congénitas, las enfermedades diarreicas, las lesiones ...
En 2015, 5,9 millions d'enfants de moins de cinq ans sont décédés (1). Les principales causes de mortalité infantile dans le monde sont la pneumonie, la prématurité, les complications durant l'accouchement, la septicémie néonatale, les anomalies congénitales, la diarrhée, les tra...
Laboratory Biossafety Manual
This report contains the results of an in-depth Training Needs Assessment (TNA) of Health Workers in the 4 project counties of the republic of Kenya – Nakuru, Kisumu, Nairobi and Bungoma. The assessment, facilitated by the UPOPs Project in close collaboration with the Ministry of Health and Minist...
